Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2015 | 04-2014 | 04-2013 | 04-2012 | 04-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,140 | -7,406 | -6,330 | -8,661 | -3,802 |
| Depreciation Amortization | 214 | 213 | 203 | 105 | 42 |
| Accounts receivable | 265 | -825 | 84 | 1 | -493 |
| Accounts payable and accrued liabilities | 433 | -223 | -472 | 96 | 636 |
| Other Working Capital | 524 | -136 | -625 | 423 | 536 |
| Other Operating Activity | 2,074 | 4,944 | 2,838 | 2,809 | 3,027 |
| Operating Cash Flow | $-9,630 | $-3,433 | $-4,302 | $-5,227 | $-54 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -114 | -234 | -57 | -519 | -84 |
| Investing Cash Flow | $-114 | $-234 | $-57 | $-519 | $-84 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -12 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 11,222 | 21 | 9,141 | 97 | 9,116 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,033 |
| Financing Cash Flow | $13,210 | $21 | $9,141 | $97 | $8,083 |
| Exchange Rate Effect | N/A | -24 | 25 | -54 | -60 |
| Beginning Cash Position | 5,891 | 9,561 | 4,754 | 10,457 | 2,572 |
| End Cash Position | 9,357 | 5,891 | 9,561 | 4,754 | 10,457 |
| Net Cash Flow | $3,466 | $-3,670 | $4,807 | $-5,703 | $7,885 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,630 | -3,433 | -4,302 | -5,227 | -54 |
| Capital Expenditure | -119 | -234 | -57 | -519 | -85 |
| Free Cash Flow | -9,749 | -3,667 | -4,359 | -5,746 | -139 |